Entero Healthcare Solutions Limited Stock Price Today (NSE: ENTERO)

Entero Healthcare Solutions Limited

1731.8070.30 (3.90%)
Market Closed

Fundamental Score

...

Entero Healthcare Solutions Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Entero Healthcare Solutions Limited share price today is 1731.80, down 3.90% on NSE/BSE as of 16 September 2026. Entero Healthcare Solutions Limited (ENTERO) is a Mid-cap company in the Pharmacy Retail sector with a market capitalisation of 7.54K (Cr). The 52-week high for ENTERO share price is 1920.00 and the 52-week low is 944.00. At a P/E ratio of 60.09x, ENTERO is currently trading above its industry average P/E of 44.45x. The company has a Return on Equity (ROE) of 6.74% and a debt-to-equity ratio of 0.34.

Entero Healthcare Solutions Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
1920.00
Low
1300.00
Volume
4.6L
Change
+39.02%

Entero Healthcare Solutions Limited share price chart: 39.02% return over the past month. 52-week high ₹1920.00, 52-week low ₹944.00.

Entero Healthcare Solutions Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
1785.101800.301666.801731.802.36L (Cr)
1812.001825.401730.001802.101.44L (Cr)
1792.901840.401792.901815.4098.79K (Cr)
1835.701850.001779.701792.901.66L (Cr)
1856.001890.501812.001828.3090.73K (Cr)
1895.101920.001841.201851.801.15L (Cr)
1857.001920.001835.001898.403.22L (Cr)
1848.001868.901811.101827.6096.17K (Cr)
1810.001863.001795.201848.001.98L (Cr)
1805.701834.001785.301797.401.67L (Cr)

Entero Healthcare Solutions Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
1807.801920.001666.801731.80-4.20%
1264.501841.501224.101809.90+43.13%
1190.001281.001164.701243.90+4.53%
1197.001213.401082.001190.00-0.58%
1224.201390.001137.601195.80-2.32%
1264.901303.201145.001216.40-3.83%
987.001259.30986.501247.80+26.42%
1148.801216.001008.001032.00-10.17%
1020.001247.501012.401104.90+8.32%
1060.001067.80944.001026.60-3.15%
1105.401203.301022.001062.70-3.86%
1116.001149.001044.901105.40-0.95%

Returns & Performance

Poor

Return on Equity (ROE)

6.74%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

12.08%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

2.73%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Entero Healthcare Solutions Limited Valuation Check

Poor

Price to Earnings (P/E)

60.09x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

44.45x

Average P/E of all peers in this sector

Market-cap Classification
Mid-cap
Balance of growth potential and stability.

Shareholding Pattern

Excellent

Promoter Holding

52.40%

% shares held by company founders/management

Poor

FII Holding

3.73%

% shares held by foreign institutional investors

Average

DII Holding

8.97%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

37.28%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

38.23%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

30.03%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

15.07%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

57.46%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.34x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

4.30x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-197.51 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Entero Healthcare Solutions Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of ENTERO across key market metrics for learning purposes.

Positive Indicators

8 factors identified

Robust Profit Growth (37.28%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (38.23%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (30.03% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Excellent EPS Growth (15.07% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (57.46% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Healthy Liquidity Position (Current Ratio: 2.46)

Observation: Strong short-term liquidity to meet obligations.

Analysis: Current ratio >1.5 indicates good working capital management.

Balanced Promoter Holding (52.40%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

5 factors identified

Below-Average Return on Equity (6.74%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Margin Pressure Concerns (2.73%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Premium Valuation Risk (P/E: 60.09x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Negative Free Cash Flow (₹-197.51 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Entero Healthcare Solutions Limited vs Pharmacy Retail Peers

Peer Comparison - Pharmacy Retail

Compare Entero Healthcare Solutions Limited with 1 other companies in the same sector

2 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
55/100
1732
₹7537.31
60.1
Average
6.74%
Poor
12.08%
Average
0.3
Excellent
57.46%
Excellent
30.03%
Excellent
0.00%
38.4/100
670
₹8048.44
38.2
Average
11.82%
Average
13.14%
Average
0.0
Excellent
28.65%
Excellent
17.56%
Excellent
0.00%

Entero Healthcare Solutions Limited PE Ratio History

Historical price-to-earnings ratio for ENTERO — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 202521.76₹1026.6047.2x
FY 202410.81₹1424.15131.7x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Entero Healthcare Solutions Limited Quarterly Performance

Latest quarterly metrics for ENTERO — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

38.23%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

37.28%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

30.03%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

57.46%

Compounded annual net profit growth over 5 years

Entero Healthcare Solutions Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for ENTERO — calculated from daily price history

84RSI 14
Overbought — RSI 84

Momentum is strong — price may be stretched. Watch for pullbacks.

SMA 50
1401
▲ Price above SMA 50 — Short-term bullish
SMA 200
1198
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
374K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Entero Healthcare Solutions Limited Financial Statements

Annual income statement, balance sheet and cash flow for Entero Healthcare Solutions Limited (ENTERO) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Entero Healthcare Solutions Limited

Loading latest quarterly results...

About ENTERO (Entero Healthcare Solutions Limited)

Entero Healthcare Solutions is a pioneering force reshaping the pharmaceutical distribution landscape in India. The company operates as a critical intermediary, connecting pharmace...utical manufacturers with a vast network of retail pharmacies, hospitals, and clinics. Entero distinguishes itself by providing a comprehensive suite of services that go beyond simple logistics. They facilitate efficient and timely delivery of a wide array of products, from essential medicines and life-saving drugs to cutting-edge therapies and specialized medical supplies. The company’s technology-driven platform optimizes inventory management, demand forecasting, and order fulfillment, ensuring that healthcare providers have access to the products they need, when they need them. By streamlining the supply chain and reducing complexities, Entero enables pharmacies and healthcare institutions to focus on patient care. Entero’s expansive product portfolio caters to diverse medical needs, encompassing everything from established pharmaceutical brands to innovative biosimilars and nutraceuticals. The company meticulously selects its product range, ensuring quality, efficacy, and alignment with prevailing healthcare standards. In addition to pharmaceuticals, Entero provides a range of surgical products, consumables, and medical devices. This comprehensive offering makes Entero a one-stop-shop for healthcare providers, simplifying procurement and reducing the burden of managing multiple suppliers. The commitment to providing a diverse and high-quality product selection underscores Entero's dedication to supporting the entire healthcare ecosystem. Furthermore, Entero Healthcare Solutions is more than just a distribution company; it is a knowledge partner and solutions provider. They actively support their retail partners with valuable data insights, marketing programs, and training initiatives. By leveraging data analytics and market research, Entero equips pharmacies with the tools they need to make informed decisions about inventory management, pricing strategies, and product promotion. Their commitment to fostering mutually beneficial partnerships extends beyond simple transactions, building trust and enabling sustained growth for both Entero and its network of healthcare providers. This dedication to innovation and customer centricity positions Entero as a leader in the evolving pharmaceutical distribution market.

Company Details

Symbol:ENTERO
Industry:Pharmacy Retail
Sector:Pharmacy Retail

Key Leadership

Mr. Prabhat Agrawal
Co-Founder, CEO, MD & Director
Mr. Prem Sethi
Co-Founder, COO & Whole-time Director
Ms. Sanu Vishal Kapoor
VP of Legal and General Counsel, Company Secretary & Compliance Officer

ENTERO Share Price: Frequently Asked Questions

What is the current share price of Entero Healthcare Solutions Limited?

Entero Healthcare Solutions Limited (ENTERO) trades at ₹1731.80 on NSE and BSE. Market cap ₹7.54K (Cr). Educational data only.

What is the P/E ratio of Entero Healthcare Solutions Limited?

Entero Healthcare Solutions Limited has a P/E of 60.09x vs industry average 44.45x.

What is the Bull Run score for Entero Healthcare Solutions Limited?

Entero Healthcare Solutions Limited has a Bull Run score of 55/100 based on 25+ financial parameters.

Does Entero Healthcare Solutions Limited pay dividends?

Entero Healthcare Solutions Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Entero Healthcare Solutions Limited?

Entero Healthcare Solutions Limited has ROE of 6.74%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Entero Healthcare Solutions Limited?

Entero Healthcare Solutions Limited has debt-to-equity of 0.34.

Is Entero Healthcare Solutions Limited a good investment?

Bull Run gives Entero Healthcare Solutions Limited a score of 55/100. This is not investment advice — consult a SEBI-registered advisor.